Tubeless Insulin Pump Market - Top Companies and Manufacturers

  • Report ID: 6368
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Companies Dominating the Tubeless Insulin Pump Landscape

    The tubeless insulin pump market is competitive and new players are emerging. Several global and regional players are competing in this sector. The sector is very innovation driven as the focus is to improve the convenience of end-users. The key players are focused on innovation, partnerships, mergers & acquisitions to increase their tubeless insulin pump market share.

    • Insulet Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Roche Diabetes Care
    • Cellenovo
    • Abbott
    • Tandem Diabetes Care
    • Valeritas, Inc
    • Medtrum Technologies

Browse Key Market Insights with Data Illustration:

In the News

  • In February 2024, Tandem Diabetes Care, Inc launched Tandem Mobi in the U.S. This will be the world’s smallest and durable insulin delivery system.
  • In April 2023, FDA approved the MiniMed 780G system. This product is equipped with the Guardian 4 sensor and has a meal-detection technology. The product is capable of adjusting the sugar level every 5 minutes.
  • In August 2022, Omnipod 5 was commercially launched in the United States by Insulet. The device can be integrated with the smartphones of users.

Author Credits:  Radhika Pawar


  • Report ID: 6368
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of tubeless insulin pump industry was over USD 11.9 billion.

The size for the tubeless insulin pump market is projected to cross USD 97.9 billion by the end of 2036 expanding at a CAGR of 19.2% during the forecast period i.e., between 2024-2036.

The major players in the market are Insulet Corporation, Tandem Diabetes Care, Roche Diabetes Care, Cellenovo, Abbott, Terumo Corporation, and others.

The tubeless insulin pumps segment is expected to register a significant revenue CAGR throughout the forecast period owing to the high rate of diabetes cases, rising ageing population, and improved healthcare infrastructure.

North America will have the largest share in the tubeless insulin pump market in the near future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample